The National Advisory Committee on Immunization (NACI) has postponed unveiling new guidance on the Oxford-AstraZeneca vaccine, which has been linked to extremely rare cases of blood clots. Mike Le Couteur looks at what may have delayed the announcement.
- 1st known case of rare blood clot linked to AstraZeneca COVID-19 vaccine confirmed in Ontario
- Why does the AstraZeneca COVID-19 vaccine age limit differ across provinces?